Mary Ann Anderson

18PUBLICATIONS
97CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Language documentation and descriptionCardiology (incl. cardiovascular diseases)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 07, 2026
Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.

|Aug 20, 2026
Richter transformation: emerging immunologic strategies beyond chemoimmunotherapy.

|Jul 24, 2026
Long-term outcomes with continuous venetoclax for relapsed chronic lymphocytic leukemia.

|Jul 07, 2026
Australasian chronic lymphocytic leukaemia consensus statement: 2026 update.

|Mar 17, 2026
Venetoclax retreatment in chronic lymphocytic leukemia is biologically rational and clinically effective.

Mathias Castonguay, Mary Ann Anderson, Philip A Thompson

|Jul 27, 2025
Real-world utilization of Bruton tyrosine kinase inhibitors in relapsed/refractory chronic lymphocytic leukemia in Australia.

Stephen P Mulligan, Philip A Thompson, Joel Wight

Pageof 3

Frequent Collaborators

7 joint publications

Constantine Tam

6 joint publications

John Francis Seymour

5 joint publications

Philip A Thompson

4 joint publications

Mark R Dowling